Upload
nicky-cranford
View
214
Download
0
Embed Size (px)
Citation preview
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
1/76
PNUR 1104Pharmacology for HealthProfessionals
Overview of Pharmacology
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
2/76
Overview of Pharmacology
PNUR 1104 Online
Pharmacology for Health
Professionals
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
3/76
Objectives
Define selected key pharmacologicalterms
Identify common sources of drugs
Discuss how drugs are classified
Differentiate between chemical,generic, and trade names of drugs
Identify sources of drug information
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
4/76
Objectives
Summarize the standards and lawswhich govern drug use.
Discuss the categories of controlledsubstances.
Discuss the role of the Food and DrugAdministration.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
5/76
Definition of Terms
Pharmacology
Drug
Drug therapy
Medication
Local effects
Systemic effects
Prototype
Drug classification
Therapeuticclassification
Pharmacologic orchemicalclassification
Chemical name
Generic name
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
6/76
Definition of Terms
Trade or brand name
Bioequivalent
Prescription drugs Non-prescription or over-the-counter
(OTC) drugs
Controlled substances
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
7/76
Sources of Drugs
Historically derived from plants
Synthetic drugs manufactured in labs
Semisynthetic drugs are naturallyoccurring substances that have beenchemically altered.
Biotechnology ( recombinantdeoxyribonucleic acid technology)
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
8/76
Drug Classification
Similar drugs are grouped togetherfor purpose of study & for ease ofprescribing.
Drugs are classified according to theireffects on particular body systems,their therapeutic uses & their
chemical characteristics.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
9/76
Drug Classification
Pharmacologic classification
Therapeutic classification
Chemical classification Other classifications: Body system,
General use, Family, Primary action,and indication.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
10/76
Drug Classification
Example: Morphine is a CNS
depressant, narcotic analgesic &opiate as well as the prototype ofnarcotic analgesics.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
11/76
Uses of Drugs
Therapeutic uses
Palliative uses
Prophylactic uses Diagnostic uses
Replacement uses
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
12/76
Drug Nomenclature
Chemical name
Generic or nonproprietary name
Trade (Brand) or proprietary name
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
13/76
Sources of Drug Information
Pharmacologytextbooks
Drug reference
books: Physiciansdesk reference(PDR), Nursingdrug reference
books
Journal articles &newsletters
Internet sites
Poison ControlCenters
Clinicians andPharmacists
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
14/76
Laws and Standards
State laws regulate some aspects ofdrug use, sale and distribution, butfederal laws regulate most majoraspects. Food and Drug Administration (FDA)
Public Health Service
Federal Trade Commission
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
15/76
Laws and Standards
Pure Food & DrugAct of 1906
Sherley
Amendment of1912
Harrison NarcoticAct of 1914
Food, Drug &Cosmetic Act of1938
Amendment of1945
Durham-HumphreyAmendment of
1952
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
16/76
Laws and Standards
Kefauver-HarrisAmendment of1962
ComprehensiveDrug AbusePrevention &Control Act of1970 (ControlledSubstance Act)
Drug RegulationReform Act of1978
Orphan Drug Actof 1983
FDA ModernizationAct of 1997
Drug Price &Patent TermRestoration
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
17/76
Categories of ControlledSubstances
Schedule I: not approved for medical use,have high abuse potential
Schedule II: used medically & have high
abuse potential Schedule III: less potential for abuse
Schedule IV: some potential for abuse
Schedule V: contain moderate amounts ofcontrolled substances
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
18/76
FDA Pregnancy Categories
Category A: Remote risk of fetalharm
Category B: Slightly More risk than A
Category C: Greater risk than B
Category D: Proven risk of fetal
harm Category X: Proven risk of fetal
harm
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
19/76
Drug Approval Process
FDA is responsible for approving allnew drugs and certain other aspectsof drug use - reviews all researchstudies related to drugs. Does not dotesting itself.
Newly developed drugs have to be
extensively tested.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
20/76
Testing Process
Begins with animal studies -reviewed by the FDA for approval togo to next step.
Next is clinical trials in humans:
Phase I, Phase II, Phase III, Phase IV(FDA evaluates data)
Double-blind, placebo controlled,crossover studies, control studies andsubject matching
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
21/76
Cellular physiology
Because all body functions, diseaseprocesses, and most drug interactionstake place at the cellular level, wemust understand cellular physiology.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
22/76
Cellular physiology
Each body cell has the capacity tofunction and respond to injury.
Although cells differ in various tissuesaccording to location & function, theyhave common characteristics: Exchange materials with their environment
Communicate with each other
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
23/76
Characteristics of InflammatoryResponse
The characteristics of theinflammatory response can be localor systemic reactions. Thesereactions may vary according to thecause and/or extent of the injury.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
24/76
Characteristics of InflammatoryResponse
LOCAL REACTION:
Erythema or redness
Heat
Edema or swelling
Pain
Purulent discharge
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
25/76
Characteristics of InflammatoryResponse
SYSTEMIC REACTION:
Leukocytosis ( increased WBCs)
Increased erythrocyte sedimentation rate(ESR)
Fever
Headache
Loss of appetite Lethargy
Weakness
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
26/76
Questions?
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
27/76
Basic Concepts andProcesses
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
28/76
Objectives
Identify factors that decreaseabsorption of an oral drug.
Identify mechanisms of drugmovement in the body.
Discuss absorption, distribution,metabolism, and excretion of drugs in
the body.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
29/76
Objectives
Discuss the main elements of thereceptor theory of drug action.
Discuss variables that effect drugactions in the body.
Identify adverse effects of drugs onthe body.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
30/76
Definition of Terms
Pharmacotherapeutics
Pharmacokinetics
Passive diffusion
Facilitated diffusion
Active transport
Absorption
Distribution
Metabolism
Excretion
Serum half-life
Pharmacodynamics
Dose
Dosage
Toxic dose
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
31/76
Definition of Terms
Lethal dose
Route ofadministration
Drug-dietinteraction
drug-druginteraction
Additive effects
Synergism
Interference
Displacement
Agonist
Antagonist
Pharmacogenetics
Pharmaco-anthropology
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
32/76
Definition of Terms
Adverse effects orside effects
Therapeutic effects
Toxic effects
Hepatotoxicity
Nephrotoxicity
Ototoxicity
Hypersensitivity orallergic reaction
Drug fever
Idiosyncrasy
Anaphylactic
reaction Drug dependence
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
33/76
Definition of Terms
Carcinogenicity
Teratogenicity
Tolerance
Cross tolerance
Metabolite
Drug action
Onset of action
Peak of action
Duration of action
Therapeutic blood
level
Peak blood level
Toxic blood level
Indication(s) Contraindications
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
34/76
Definition of Terms
Precautions
Incompatibility
Loading dose
Maintenance dose
Cumulative effects
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
35/76
Mechanisms of Drug Movement
To act on body cells, drugs given forsystemic effects must reach adequateconcentrations in blood & other tissue fluids
surrounding the cells. Thus, they mustenter the body & be circulated in thebloodstream. After they act on cells, theymust be eliminated from the body, as are
other chemical bodies.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
36/76
Mechanisms of Drug Movement
Passive diffusion: higher to lower
Facilitated diffusion: drug moleculescombine with a carrier substance
Active transport: lower to higher
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
37/76
Mechanisms of Drug Movement
Drug movement & therefore drugaction are affected by a drugs abilityto cross cell membranes. Cell
membranes are complex structurescomposed of lipid & protein:
Lipid soluble drugs
Water soluble drugs
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
38/76
Pharmacokinetics
Absorption:
Dosage form
Route of
administration GI function
Increased gastricemptying
Food in thestomach
SQ or IM injections
IV therapy
Skin absorption
Mucous membrane
Lungs
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
39/76
Pharmacokinetics
Distribution: involves thetransport of drug molecules withinthe body. Carried to sites of action, metabolism &
excretion Depends largely on adequacy of circulation
Protein binding
Only free or unbound portion of drug acts onbody cells
Drug distribution in CNS is unique
Drug distribution during pregnancy &lactation is unique
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
40/76
Pharmacokinetics
Metabolism: method by which drugsare inactivated or biotransformed bythe body. Changed into one or more inactive metabolites
& excreted
Kidney can only excrete water solublesubstances
Most drugs are metabolized by enzymes in theliver
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
41/76
Pharmacokinetics
Metabolism:
Enzyme induction
Enzyme inhibition
Rate of metabolism
Oral drugs absorbed in the GI tract thatare extensively metabolized in the liver
reduce systemic circulation
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
42/76
Pharmacokinetics
Excretion: refers to elimination of adrug from the body.
Requires adequate functioning of the
circulatory system & organs of excretion
Most drugs are excreted by the kidneys Bile
Feces
Lungs
Skin
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
43/76
Pharmacokinetics
Serum half-life: also called elimination half-time, isthe time required for the serum concentration of adrug to decrease by 50%.
Determined primarily by drugs rates ofmetabolism & excretion
Short half life require more frequentadministration
4-5 half lives are required to achieve steady-state concentrations
Eliminated gradually over several half-lives
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
44/76
Pharmacodynamics
Receptor theory of drug action
Specific receptors: enzymes, proteins,nucleic acids
Changes in cellular metabolism
Changes permeability of cell membrane
Modifies physiologic process of cell
Receptors vary in type, location &number
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
45/76
Pharmacodynamics
When drug molecules chemically bindwith cell receptors, pharmacologiceffects are agonism or antagonism:
Agonists
Antagonists
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
46/76
Pharmacodynamics
Nonreceptor drug actions: relativelyfew drugs act by other mechanisms.
Antacids
Osmotic diuretics
Structurally similar to nutrients
Metal chelating agents
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
47/76
Variables That Affect DrugActions
Drug related variables:
Dosage
Route of administration
Drug-diet interaction
Drug-drug interactions
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
48/76
Drug-Drug Interactions
Additive effects
Synergism orpotentiation
Interference Displacement
Specific antidote
Decreasedintestinal
absorption due tobinding
activation ofenzymes
Increasedexcretion
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
49/76
Client Related Variables
Age
Body weight
Genetic ðniccharacteristics
Gender
Pathologicconditions
Psychologicalconsiderations
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
50/76
AGE
Children
Pregnancy
Newborns
Older infants
1 -12 year olds
After age 12
Older adults (65 & over)
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
51/76
Body Weight
Larger than average person requiresmore than average person.
Nurse may have to calculate by mgper kg of weight.
Fat cells may store drug and releaselater.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
52/76
Gender
Altered responses to drugs have beendemonstrated possibly due tohormonal influence.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
53/76
Pathologic Conditions
Disorders may cause an alteration inthe pharmacokinetic process:
Hypotension, shock, low plasma
Vomiting, diarrhea, malabsorption
Liver or kidney disease
Malnutrition
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
54/76
Psychological Considerations
Placebo response
Attitude and expectations
Compliance
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
55/76
Adverse Effects of Drugs
All drugs can produce adverse effects
May be common, rare, mild or severe
May occur with usual therapeuticdoses of drugs and are often calledside effects.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
56/76
Adverse Effects of Drugs
CNS effects
GI effects
Hematologic effects
Hepatotoxicity
Nephrotoxicity
HypersensitivityDrug fever
Idiosyncrasy
Drug dependence Carcinogenicity
Teratogenicity
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
57/76
Tolerance and Cross-Tolerance
Drug tolerance
Cross-tolerance
Tachyphylaxis
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
58/76
Questions?
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
59/76
Nursing Process in DrugTherapy
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
60/76
Objectives
Discuss general principles of drugtherapy.
Identify information to be included ina medication history.
Identify the Food and DrugAdministration Pregnancy Categories
for drugs.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
61/76
Introduction
Drug therapy is one of the manynursing responsibilities in client care.To fulfill this responsibility the nurse
must be: Be knowledgeable about pharmacology
Monitor responses to drug therapy
Teach clients and families about drugs
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
62/76
Using Prototypes Approach toStudy Pharmacology
Concentrate on therapeuticclassifications, groups of drugs &prototypes of those groups.
Know major characteristics for agroup.
Set guidelines for effective study
L l R ibiliti f th
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
63/76
Legal Responsibilities of theNurse
Nurses are legally empowered to givemedications ordered by licensedphysicians and dentists (in all states
but GA, NPs).
When giving medications, the nurse islegally responsible for safe and
accurate administration (5 Rights).
Legal Responsibilities of the
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
64/76
Legal Responsibilities of theNurse
The nurse is expected to have sufficient drugknowledge to recognize & question erroneous orders.
The nurse is responsible for storing narcotics & othercontrolled substances in locked containers, administeronly to people for whom they are prescribed,recording each dose given on the appropriate form &on MAR, counting the amount of each drug at the endof shift and reporting any discrepancies.
Legal Responsibilities of the
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
65/76
Legal Responsibilities of theNurse
The nurse is expected to observeclients for therapeutic & adverseeffects, as well as, teach clients safe
and effective self-administration ofdrugs when indicated.
Medication errors can be eliminated
by following safe practices &guidelines.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
66/76
Applying the Nursing Process
The nursing process is a systematic way ofgathering information and using thatinformation to plan, provide, and toevaluate client care and outcomesrequired for drug therapy.
AssessmentNursing diagnosisPlanning/goals
Nursing interventionsEvaluation
General Principles of Drug
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
67/76
General Principles of DrugTherapy
The goal of drug therapy
Benefits should outweigh the adverseeffects
Drug therapy should be individualized
Drug costs and effects on quality oflife should be considered
General Drug Selection &
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
68/76
General Drug Selection &Dosage Considerations
Use as few drugs in as few doses aspossible
Individual drugs allow greater flexibility &
individualization of dosage than fixed The least amount of the least potent drug
that will yield therapeutic benefit should begiven to decrease adverse effects.
General Drug Selection &
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
69/76
General Drug Selection &Dosage Considerations
Recommended dosages are listed inamounts likely to be effective for mostpeople, but are only guidelines to beinterpreted according to client
characteristics. Treatment with a particular drug can bestarted rapidly or slowly.
Different salts of the same drug rarelydiffer pharmacologically.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
70/76
Drug Therapy in Children
Special considerations Pharmacokinetics less predictable Fewer studies/ less research Neonates immature kidney/liver function Most meds given to adults are given to
children as well Use general principles, techniques of drug
administration as with adults but with
additional guidelines
Additional Guidelines for Drug Administration to
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
71/76
Additional Guidelines for Drug Administration toChildren
Drug therapy is guided by childs age,weight, and level of growth anddevelopment.
Choices of drug is often restricted.
Safe therapeutic dosage ranges are lesswell defined for children.
Use the oral route of administration whenpossible.
Use thigh muscle for IM injections. Child-proof containers.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
72/76
Drug Therapy for Older Adults
Adverse effects are especially likely tooccur due to physiological changesassociated with aging, pathologic changesdue to disease processes, multiple drug
therapy for acute and chronic disorders,impaired memory & cognition & difficultyin complying with medication orders.
The overall goal may be care instead ofcure with efforts to prevent or controlsymptoms & maintain ability of ADLfunction .
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
73/76
Additional Guidelines for Drug Therapy in theOlder Adult
Physiologic age (organ function) is moreimportant than chronological age.
S&S attributed to age may be caused bydrug therapy.
Medications should be taken only whennecessary.
Review current meds before prescribingnew medications.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
74/76
Additional Guidelines for Drug Therapyin the Older Adult
Give smallest number of effective drugs.
Give for shortest effective time needed andreassess periodically.
Smallest number of doses necessaryprescribed to least disrupt routine.
Start slow, go slow.
Use non-drug measures as much as
possible.
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
75/76
Additional Guidelines for Drug Therapyin the Older Adult
Long term drug therapy - home safety/effectiveness guidelines: Label containers/Magnifying glass Use easy open containers
Special devices & methods Enlist help of family members Observe for changes in S&S related to
adverse drug reactions as opposed to
aging process
7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1
76/76
Questions?